Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS.NS) share price
Aarey Drugs & Pharmaceuticals Limited (NSE:AAREYDRUGS.NS) last traded at INR 109.21, down 0.16% on the day (quote 2026-11-08 09:59 UTC), with a market cap of INR 348.1 Cr and a 52-week range of INR 50.31 to INR 114.8.
| Exchange | NSE |
|---|---|
| Currency | INR |
| Last price | INR 109.21 |
| 1-day move | -0.16% |
| 52-week range | INR 50.31 - INR 114.8 |
| Market cap | INR 348.1 Cr |
| From 52-week high | -4.90% |
| Volume vs average | 0.1x |
| Falling Shares risk score | 2/100 (LOW) |
| Country | India |
| ISIN | INE198H01019 |
Frequently asked questions
Why is Aarey Drugs & Pharmaceuticals Limited falling today?
Aarey Drugs & Pharmaceuticals Limited (NSE:AAREYDRUGS.NS) is down 0.16% at its latest quote and trades 4.9% below its 52-week high. A price fall alone does not identify a cause: Falling Shares Intelligence links a move to a filing, order or news item only when a source supports it.
What is the Aarey Drugs & Pharmaceuticals Limited share price today?
Aarey Drugs & Pharmaceuticals Limited (NSE:AAREYDRUGS.NS) last traded at INR 109.21, a -0.16% move on the day as of 2026-11-08 09:59 UTC. Market data comes from public feeds and may be delayed; it is not investment advice.
What is the 52-week range of Aarey Drugs & Pharmaceuticals Limited?
Aarey Drugs & Pharmaceuticals Limited's 52-week low is INR 50.31 and its 52-week high is INR 114.8; the shares trade 4.9% below the high.
What is the market cap of Aarey Drugs & Pharmaceuticals Limited?
Aarey Drugs & Pharmaceuticals Limited has a market capitalisation of about INR 348.1 Cr at the latest price.
What are the risks of investing in Aarey Drugs & Pharmaceuticals Limited?
Falling Shares Intelligence rates Aarey Drugs & Pharmaceuticals Limited 2/100 (LOW) on price stress, volume and disclosure signals. Risk scores are analytical indicators, not allegations or investment advice. Review exchange filings and the company's own disclosures before any decision.
Data is compiled from public exchange feeds and may be delayed. Not investment advice.
Wung Thomas, Editor-in-Chief: wungthomas@fallingshares.com. General enquiries and corrections: info@fallingshares.com